Expenses and Other Non-Operating (Income) Expense, Net (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2024 |
Dec. 31, 2023 |
| Expenses And Other Non Operating Income Expense Net [Abstract] |
|
|
| Schedule of Sales and Marketing Expenses |
|
Sales and marketing expenses
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
|
(as restated) |
|
|
(as restated) |
|
Advertisement and publicity expenses |
|
$ |
144,584 |
|
|
|
635,166 |
|
Employee salaries and benefits |
|
|
1,371,468 |
|
|
|
1,788,941 |
|
Consultancy charges |
|
|
1,602,332 |
|
|
|
1,538,729 |
|
Share-based payments to employees |
|
|
2,649,012 |
|
|
|
375,721 |
|
Share-based payments to related parties |
|
|
963,858 |
|
|
|
— |
|
Total |
|
|
6,731,254 |
|
|
|
4,338,557 |
|
|
| Schedule of General and Administrative Expenses |
|
General and administrative expenses
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
|
(as restated) |
|
|
(as restated) |
|
IT expenses |
|
$ |
1,135,355 |
|
|
|
1,066,708 |
|
Legal and professional expenses |
|
|
2,274,891 |
|
|
|
5,569,989 |
|
Business development expenses |
|
|
777,161 |
|
|
|
7,136,168 |
|
Employee salaries and benefits |
|
|
4,340,558 |
|
|
|
3,506,501 |
|
Consultancy charges |
|
|
3,472,170 |
|
|
|
8,223,297 |
|
Share-based payments to employees |
|
|
2,543,621 |
|
|
|
1,739,294 |
|
Share-based payments to related parties |
|
|
2,083,647 |
|
|
|
39,501,701 |
|
Share-based payments for consultancy |
|
|
485,080 |
|
|
|
18,417,816 |
|
Other |
|
|
874,045 |
|
|
|
1,479,026 |
|
Total |
|
|
17,986,528 |
|
|
|
86,640,500 |
|
|
| Schedule of Other Non-operating (income)/ expenses, net |
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2024 $ |
|
|
Six months ended June 30, 2023 $ |
|
Foreign exchange (gain) loss |
|
108,224 |
|
|
327,383 |
|
R&D credits |
|
— |
|
|
(496,448 |
) |
Other, net |
|
(408 |
) |
|
(2,686) |
|
Total |
|
107,816 |
|
|
(171,751 |
) |
|
Other non-operating (income) expense, net
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
|
(as restated) |
|
|
(as restated) |
|
Foreign exchange loss |
|
$ |
375,298 |
|
|
|
194,524 |
|
R&D credits |
|
|
(497,978 |
) |
|
|
(467,563 |
) |
Other, net |
|
|
(2,686 |
) |
|
|
16,380 |
|
Total |
|
|
125,366 |
|
|
|
(256,659 |
) |
|